John Gary Csernansky

Northwestern University, Evanston, IL 
schizophrenia, Alzheimer's Disease
"John Csernansky"
Mean distance: 26716.5 (cluster 19)
Cross-listing: Alzheimer's Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Rodríguez G, Neugebauer NM, Yao KL, et al. (2017) Δ9-tetrahydrocannabinol (Δ9-THC) administration after neonatal exposure to phencyclidine potentiates schizophrenia-related behavioral phenotypes in mice. Pharmacology, Biochemistry, and Behavior
Gollan JK, Dong H, Bruno D, et al. (2017) Basal forebrain mediated increase in brain CRF is associated with increased cholinergic tone and depression. Psychiatry Research. 264: 76-81
Montalvo-Ortiz JL, Fisher DW, Rodríguez G, et al. (2017) Histone deacetylase inhibitors reverse age-related increases in side effects of haloperidol in mice. Psychopharmacology
Blizinsky KD, Diaz-Castro B, Forrest MP, et al. (2016) Reversal of dendritic phenotypes in 16p11.2 microduplication mouse model neurons by pharmacological targeting of a network hub. Proceedings of the National Academy of Sciences of the United States of America
Gollan JK, Buchanan A, Connolly M, et al. (2015) Differences in the neural correlates of affective responses in depressed and healthy women. Psychiatry Research
Herting MM, Uban KA, Williams PL, et al. (2015) Default Mode Connectivity in Youth With Perinatally Acquired HIV. Medicine. 94: e1417
Coccaro EF, Lee R, McCloskey M, et al. (2015) Morphometric analysis of amygdla and hippocampus shape in impulsively aggressive and healthy control subjects. Journal of Psychiatric Research. 69: 80-6
Gollan JK, Connolly M, Buchanan A, et al. (2015) Neural substrates of negativity bias in women with and without major depression. Biological Psychology. 109: 184-191
Smith MJ, Cobia DJ, Reilly JL, et al. (2015) Cannabis-related episodic memory deficits and hippocampal morphological differences in healthy individuals and schizophrenia subjects. Hippocampus
Jarskog LF, Lowy MT, Grove RA, et al. (2015) A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy. Schizophrenia Research. 164: 136-42
See more...